首页 | 本学科首页   官方微博 | 高级检索  
检索        

多发性骨转移癌骨痛的内照射治疗
引用本文:游金辉.多发性骨转移癌骨痛的内照射治疗[J].川北医学院学报,2007,22(1):60-63.
作者姓名:游金辉
作者单位:川北医学院附属医院核医学科,四川,南充,637000
摘    要:89SrCl2、153Sm-EDTMP、188Re-HEDP以及与它们相关的联合治疗方法对多发性骨转移瘤患者的姑息止痛效果为70%-90%以上,其疗效与病理类型密切相关;153Sm-EDTMP的骨髓抑制作用较89SrCl2严重,临床可首选188Re-HEDP或89SrCl2。

关 键 词:骨转移癌  骨痛  89SrCl2  153Sm-EDTMP  88Re-HEDP  治疗
文章编号:1005-3697(2007)01-0060-04
修稿时间:2006-11-02

Therapy on Bone Pain of Multiple Metastases with Radio-pharmaceuticals
YOU Jin-hui.Therapy on Bone Pain of Multiple Metastases with Radio-pharmaceuticals[J].Journal of North Sichuan Medical College,2007,22(1):60-63.
Authors:YOU Jin-hui
Institution:The Department of Nuclear Medicine , the Affiliated Hospital of North Sichnan Medical College,Sichnan 637000, China
Abstract:The relief rate of bone pain in metastases was between 70% and more than 90% treated by 89SrC1_2,153Sm-EDTMP,188Re-HEDP,and combined with radio-pharmaceuticals.The treatment effect of them was mostly correlated with tumor's pathological type.The marrow depress effect of 153Sm-EDTMP was higher than that of 89SrC1_2.So,188Re-HEDP or 89SrC1_2 can be chosen primarily in treating bone metastasis.
Keywords:89SrCl2  153Sm-EDTMP  88Re-HEDP
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号